Abstract
A possibility of the use of thymalin was studied in children with diabetes mellitus using adequate immunohormonal investigations. Clinico-metabolic investigations proved the efficacy of the use of the new immunomodulator thymalin in multimodality therapy of diabetes mellitus in children.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Adjuvants, Immunologic / therapeutic use*
-
Adolescent
-
Child
-
Child, Preschool
-
Chronic Disease
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Diabetes Mellitus, Type 1 / immunology
-
Drug Evaluation
-
Drug Therapy, Combination
-
Female
-
Humans
-
Insulin / therapeutic use
-
Male
-
Thymus Hormones / therapeutic use*
Substances
-
Adjuvants, Immunologic
-
Insulin
-
Thymus Hormones
-
thymalin